Search

Search results

4262 results found

Evidence for Left Atrial Volume Being an Indicator of Adverse Events in Patients With Acute Pulmonary Embolism: Retrospective Case-control Pilot Study.

Kirkbride, Rachael R, Benedikt H Heidinger, Antonio C Monteiro Filho, Alexander Brook, Daniela M Tridente, Dominique C DaBreo, Brett J Carroll, et al. 2022. “Evidence for Left Atrial Volume Being an Indicator of Adverse Events in Patients With Acute Pulmonary Embolism: Retrospective Case-Control Pilot Study.”. Journal of Thoracic Imaging 37 (3): 173-80.

Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Aslam, Anum, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F Sabottke, Victoria Chernyak, and Sara C Lewis. 2021. “Assessing Locoregional Treatment Response to Hepatocellular Carcinoma: Comparison of Hepatobiliary Contrast Agents to Extracellular Contrast Agents.”. Abdominal Radiology (New York) 46 (8): 3565-78.

Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH-A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR.

Varma, Gopal, Pankaj Seth, Patricia Coutinho de Souza, Cody Callahan, Jocelin Pinto, Manushka Vaidya, Olmo Sonzogni, Vikas Sukhatme, Gerburg M Wulf, and Aaron K Grant. 2021. “Visualizing the Effects of Lactate Dehydrogenase (LDH) Inhibition and LDH-A Genetic Ablation in Breast and Lung Cancer With Hyperpolarized Pyruvate NMR.”. NMR in Biomedicine 34 (8): e4560.

Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable Hepatocellular Carcinoma After Locoregional Treatment.